SIMCERE PHARMAC. GRP LTD (S2P) — Financial Flexibility Index
SIMCERE PHARMAC. GRP LTD (S2P) has a Financial Flexibility Index of 0.54x as of December 2025. Free cash flow of €2.88 Billion (operating CF €2.01 Billion minus capex €862.20 Million) represents 1% of total liabilities (€5.31 Billion). Also explore SIMCERE PHARMAC. GRP LTD (S2P) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SIMCERE PHARMAC. GRP LTD Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for SIMCERE PHARMAC. GRP LTD across 5 annual periods. Check S2P cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for SIMCERE PHARMAC. GRP LTD (2021–2025)
Year-by-year free cash flow to debt coverage for SIMCERE PHARMAC. GRP LTD. For the full company profile including market capitalisation, see SIMCERE PHARMAC. GRP LTD market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | €2.88 Billion | €2.01 Billion | €5.31 Billion | ▲ +11.7% |
| 2024 | 0.48x | €2.15 Billion | €1.39 Billion | €4.44 Billion | ▲ +55.7% |
| 2023 | 0.31x | €1.13 Billion | €151.05 Million | €3.63 Billion | ▼ -44.2% |
| 2022 | 0.56x | €2.03 Billion | €1.35 Billion | €3.64 Billion | ▲ +27354.5% |
| 2021 | 0.00x | €7.52 Million | €-201.97 Million | €3.70 Billion | — |